Potential Involvement of LncRNAs in Cardiometabolic Diseases

被引:4
|
作者
Ilieva, Mirolyuba [1 ]
Uchida, Shizuka [1 ]
机构
[1] Aalborg Univ, Ctr RNA Med, Dept Clin Med, DK-2450 Copenhagen SV, Denmark
关键词
cardiovascular; genetics; lncRNA; metabolism; LONG NONCODING RNA; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; PULMONARY-HYPERTENSION; NEGATIVE REGULATOR; WESTERN DIET; RISK-FACTORS; OBESITY;
D O I
10.3390/genes14010213
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Characterized by cardiovascular disease and diabetes, cardiometabolic diseases are a major cause of mortality around the world. As such, there is an urgent need to understand the pathogenesis of cardiometabolic diseases. Increasing evidence suggests that most of the mammalian genome are transcribed as RNA, but only a few percent of them encode for proteins. All of the RNAs that do not encode for proteins are collectively called non-protein-coding RNAs (ncRNAs). Among these ncRNAs, long ncRNAs (lncRNAs) are considered as missing keys to understand the pathogeneses of various diseases, including cardiometabolic diseases. Given the increased interest in lncRNAs, in this study, we will summarize the latest trend in the lncRNA research from the perspective of cardiometabolism and disease by focusing on the major risk factors of cardiometabolic diseases: obesity, cholesterol, diabetes, and hypertension. Because genetic inheritance is unavoidable in cardiometabolic diseases, we paid special attention to the genetic factors of lncRNAs that may influence cardiometabolic diseases.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Targeting Human lncRNAs for Treating Cardiometabolic Diseases
    Ruan, Xiangbo
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (03) : 655 - 662
  • [2] Targeting Human lncRNAs for Treating Cardiometabolic Diseases
    Xiangbo Ruan
    Cardiovascular Drugs and Therapy, 2021, 35 : 655 - 662
  • [3] Involvement of lncRNAs and Macrophages: Potential Regulatory Link to Angiogenesis
    Jia, Yang
    Zhou, Yedi
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [4] Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases
    Zsófia Gál
    András Gézsi
    Ágnes F. Semsei
    Adrienne Nagy
    Monika Sultész
    Zsuzsanna Csoma
    Lilla Tamási
    Gabriella Gálffy
    Csaba Szalai
    Journal of Translational Medicine, 18
  • [5] Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases
    Gal, Zsofia
    Gezsi, Andras
    Semsei, Agnes F.
    Nagy, Adrienne
    Sultesz, Monika
    Csoma, Zsuzsanna
    Tamasi, Lilla
    Galffy, Gabriella
    Szalai, Csaba
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [6] Yogurt and Cardiometabolic Diseases: A Critical Review of Potential Mechanisms
    Fernandez, Melissa Anne
    Panahi, Shirin
    Daniel, Noemie
    Tremblay, Angelo
    Marette, Andre
    ADVANCES IN NUTRITION, 2017, 8 (06) : 812 - 829
  • [7] LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases
    Huang, Shi-Feng
    Peng, Xiao-Fei
    Jiang, Lianggui
    Hu, Ching Yuan
    Ye, Wen-Chu
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Identification of potential new targets for the prevention and treatment of cardiometabolic diseases
    Moreno-Viedma, V.
    Amor, M.
    Sarabi, A.
    Bilban, M.
    Zeyda, M.
    Stulnig, T. M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (17-18) : 736 - 737
  • [9] Eicosanoids in periodontal diseases: Potential for systemic involvement
    Damare, SM
    Wells, S
    Offenbacher, S
    RECENT ADVANCES IN PROSTAGLANDIN, THROMBOXANE, AND LEUKOTRIENE RESEARCH, 1997, 433 : 23 - 35
  • [10] Molecular Aspects of Cardiometabolic Diseases: From Etiopathogenesis to Potential Therapeutic Targets
    Bernatova, Iveta
    Bartekova, Monika
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)